Cyberounds Logo
September 26, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Endometrial Cancer
CME credit is no longer available for this conference.
Yevgeniya Ioffe, M.D., and Israel Zighelboim, M.D.

Dr. Ioffe is Clinical Fellow, Division of Gynecologic Oncology, and Dr. Zighelboim is Assistant Professor, Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO.

Within the past 12 months, Drs. Ioffe and Zighelboim report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.

Release Date: 10/10/2011
Termination Date: 10/10/2014

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the clinical presentation and disease characteristics of patients with endometrial cancer
  • Apply the epidemiology and risk factors associated with the development of endometrial cancer to their patients
  • Detail surgical and non-surgical treatment options available for the management of patients with endometrial cancer
  • List the most common cancer susceptibility syndromes associated with endometrial cancer
  • Apply information about outcome and prognosis to patients with endometrial cancer

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity